Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
# Financial Risk Summary: Poly Medicure Limited Poly Medicure faces its most material financial exposure through **compliance risk (10.0/10 score) and Extended Producer Responsibility (EPR) obligations**, with estimated remediation costs of ₹3–10 crore annually—representing 0.2–0.6% of ₹1,601.8 crore revenue. The company's **unknown EPR applicability status (6.5/10 exposure) is a critical gap** given India's mandatory plastic waste management rules; delayed compliance could trigger regulatory penalties and supply chain disruptions in the medical device sector. While scope 1 and 2 emissions reporting shows zero or unreported data, **non-compliance with SEBI BRSR Core Expansion disclosures carries delisting risk**, particularly if Poly Medicure qualifies as a top-tier listed entity, making transparent GHG and environmental accounting mandatory. Immediate priorities: clarify EPR regulatory obligations under the Plastic Waste Management Rules and establish robust BRSR data governance to mitigate SEBI enforcement action.
Source: POLY MEDICURE LIMITED BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.